Global HBV burden: guesstimates and facts (original) (raw)
WHO. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Google Scholar
Collaborators TPO. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403. Article Google Scholar
Stanaway JD, et al. The global burden of viral hepatitis from, 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–8. ArticlePubMedPubMed Central Google Scholar
McMahon BJ, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151(4):599–603. ArticlePubMedCAS Google Scholar
Childs L, Roesel S, Tohme RA. Status and progress of hepatitis B control through vaccination in the South-East Asia region, 1992–2015. Vaccine. 2018;36(1):6–14. ArticlePubMed Google Scholar
Iorio R, et al. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis. 2007;45(8):943–9. ArticlePubMed Google Scholar
Kubo A, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014;160(12):828–35. ArticlePubMedPubMed Central Google Scholar
Anja MH, Gregory LA, Yvan JFH. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15(1):7–16. Article Google Scholar
Ott JJ, et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9. ArticlePubMedCAS Google Scholar
Ott JJ, et al. Time trends of chronic HBV infection over prior decades - A global analysis. J Hepatol. 2017;66(1):48–54. ArticlePubMed Google Scholar
Raimondo G, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652–7. ArticlePubMed Google Scholar
Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017;31(3):249–55. ArticlePubMedCAS Google Scholar
Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol. 2016;22(4):423–31. ArticlePubMedPubMed Central Google Scholar
Lin CL, Kao JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28(1):10–7. ArticlePubMedCAS Google Scholar
Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis (Eurohep). Gut. 2000;46:420–6. ArticlePubMedPubMed CentralCAS Google Scholar
Terrault NA, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–83. ArticlePubMed Google Scholar
Jonas MM, et al. Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis. Hepatology. 2016;63(1):307–18. ArticlePubMedCAS Google Scholar
World Health Organization. World health statistics 2016: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2016 (Feb 7 2018). Google Scholar
Schweitzer A, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55. ArticlePubMed Google Scholar
Lemoine M, Thursz MR. Battlefield against hepatitis B infection and HCC in Africa. J Hepatol. 2017;66(3):645–54. ArticlePubMed Google Scholar
Breakwell L, et al. The status of hepatitis B control in the African region. Pan Afr Med J. 2017;27(Suppl 3):17. PubMedPubMed Central Google Scholar
Komas NP, et al. Cross-sectional study of hepatitis B virus infection in rural communities, central African Republic. BMC Infect Dis. 2013;13(1):286. ArticlePubMedPubMed Central Google Scholar
Bernier RH, et al. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol. 1982;116(2):199–211. ArticlePubMedCAS Google Scholar
Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37(s1):S9–19. ArticlePubMed Google Scholar
Shimakawa Y, et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia. Gut. 2016;65(12):2007–16. ArticlePubMed Google Scholar
Kirk GD, et al. The Gambia liver cancer study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology. 2004;39(1):211–9. ArticlePubMed Google Scholar
Kew MC, et al. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans. J Med Virol. 2005;75(4):513–21. ArticlePubMedCAS Google Scholar
Chen DS, et al. Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia. J Hepatol. 2013;59(5):1073–80. ArticlePubMed Google Scholar
Stockdale AJ, Phillips RO, Geretti AM, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: ‘The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa’ by Lemoine et al. Gut. 2016;65(5):882–4. ArticlePubMedCAS Google Scholar
Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol. 2011;11:66. ArticlePubMedPubMed Central Google Scholar
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42:S206–14. ArticlePubMedPubMed Central Google Scholar
World Health Organization, Regional Office of Southeast Asia., Regional action plan for viral hepatitis in South-East Asia: 2016–2021. 2017: New Delhi.
WHO. Global hepatitis report 2017 executive summary. Geneva: World Health Organization; 2017. Google Scholar
Kim H, et al. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med. 2013;28(4):413–9. ArticlePubMedPubMed Central Google Scholar
Leroi C, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. Int J Infect Dis. 2016;51:36–43. ArticlePubMed Google Scholar
The Kirby Institute. Hepatitis B and C in Australia annual surveillance report supplement 2016. Sydney: UNSW; 2016. Google Scholar
Liang P, et al. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992–2006: a mathematical model analysis. J Theor Biol. 2015;386:115–21. ArticlePubMed Google Scholar
Ott JJ, et al. Time trends of chronic HBV infection over prior decades—a global analysis. J Hepatol. 2017;66(1):48–54. ArticlePubMed Google Scholar
Liang P, et al. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992–2006: a mathematical model analysis. J Theor Biol. 2015;386:115–21. ArticlePubMed Google Scholar
World Health Organization, Regional Office for the Eastern Mediterranean, The growing threats of hepatitis B and C in the Eastern Mediterranean region: a call for action in Regional Committee for the Eastern Mediterranean. 2009.
Allison RD, et al. Hepatitis B control among children in the Eastern Mediterranean region of the World Health Organization. Vaccine. 2016;34(21):2403–9. ArticlePubMed Google Scholar
Ali M, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011;8:102. ArticlePubMedPubMed Central Google Scholar
Talaat M, et al. Case-control study to evaluate risk factors for acute hepatitis B virus infection in Egypt. East Mediterr Health J. 2010;16(1):4–9. ArticlePubMedCAS Google Scholar
Talaat M, et al. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control. 2003;31(8):469–74. ArticlePubMed Google Scholar
Usman HR, et al. Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Epidemiol Infect. 2003;130(2):293–300. ArticlePubMedPubMed CentralCAS Google Scholar
European Centre for Disease Prevention and Control. Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC; 2016.
Pruss-Ustun A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005;48(6):482–90. ArticlePubMed Google Scholar
Hofstraat SHI, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873–85. ArticlePubMedCAS Google Scholar
CDC., Viral hepatitis surveillance—United States 2015. 2017.
Kowdley KV, et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56(2):422–33. ArticlePubMed Google Scholar
Ioannou GN. Hepatitis B virus in the united states: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med. 2011;154(5):319–28. ArticlePubMed Google Scholar
Devesa M, Pujol FH. Hepatitis B virus genetic diversity in Latin America. Virus Res. 2007;127(2):177–84. ArticlePubMedCAS Google Scholar
Echevarría JM, León P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cadernos de Saúde Pública. 2003;19:1583–91. ArticlePubMed Google Scholar
Souto FJD. Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21st century. Rev Soc Bras Med Trop. 2016;49:11–23. ArticlePubMed Google Scholar
Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607–28. ArticlePubMedPubMed Central Google Scholar
Ai-Faleh FZ, et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect. 1999;38(3):167–70. Article Google Scholar
Lin CL, Kao JH. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination. Hepatol Int. 2018;12(2):94–6. ArticlePubMed Google Scholar
Brown RS Jr, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology. 2016;63(1):319–33. ArticlePubMedCAS Google Scholar
Pan CQ, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–34. ArticlePubMedCAS Google Scholar
Stasi C. Global burden of chronic hepatitis B virus infection in prison. Epidemiol Open Access. 2017;07(05):58. Google Scholar
WHO. Report for the safe injection global network (SIGN) meeting 2010. Geneva: World Health Organization; 2010. Google Scholar
Degenhardt L, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the global burden of disease study 2013. Lancet Infect Dis. 2016;16(12):1385–98. ArticlePubMed Google Scholar
Spradling PR, et al. Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings. Clin Infect Dis. 2016;63(9):1205–8. PubMedCAS Google Scholar
Lok AS, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis. Hepatology. 2016;63(1):284–306. ArticlePubMedCAS Google Scholar
Lin CL, Kao JH. Review article: novel therapies for hepatitis B virus cure—advances and perspectives. Aliment Pharmacol Ther. 2016;44(3):213–22. ArticlePubMedCAS Google Scholar
Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2015;29(6):907–17. ArticlePubMed Google Scholar
Wendland A, et al. Undocumented migrant women in Denmark have inadequate access to pregnancy screening and have a higher prevalence hepatitis B virus infection compared to documented migrants in Denmark: a prevalence study. BMC Public Health. 2016;16:426. ArticlePubMedPubMed Central Google Scholar
United Nations, Department of Economic and Social Affairs, Population Division, Trends in International Migrant Stock: The 2013 Revision (POP/DB/MIG/Stock/Rev.2013).